11-67991615-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_030930.4(UNC93B1):​c.1725C>G​(p.Pro575Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00886 in 1,499,800 control chromosomes in the GnomAD database, including 74 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P575P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0059 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0092 ( 68 hom. )

Consequence

UNC93B1
NM_030930.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.62

Publications

0 publications found
Variant links:
Genes affected
UNC93B1 (HGNC:13481): (unc-93 homolog B1, TLR signaling regulator) This gene encodes a protein that is involved in innate and adaptive immune response by regulating toll-like receptor signaling. The encoded protein traffics nucleotide sensing toll-like receptors to the endolysosome from the endoplasmic reticulum. Deficiency of the encoded protein has been associated with herpes simplex encephalitis. [provided by RefSeq, Feb 2014]
UNC93B1 Gene-Disease associations (from GenCC):
  • herpes simplex encephalitis, susceptibility to, 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 11-67991615-G-C is Benign according to our data. Variant chr11-67991615-G-C is described in ClinVar as [Benign]. Clinvar id is 782776.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.62 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00591 (899/152182) while in subpopulation NFE AF = 0.00917 (623/67948). AF 95% confidence interval is 0.00857. There are 6 homozygotes in GnomAd4. There are 420 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UNC93B1NM_030930.4 linkc.1725C>G p.Pro575Pro synonymous_variant Exon 11 of 11 ENST00000227471.7 NP_112192.2 Q9H1C4
UNC93B1XM_011545290.1 linkc.1314C>G p.Pro438Pro synonymous_variant Exon 9 of 9 XP_011543592.1
UNC93B1XM_011545291.3 linkc.1170C>G p.Pro390Pro synonymous_variant Exon 8 of 8 XP_011543593.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UNC93B1ENST00000227471.7 linkc.1725C>G p.Pro575Pro synonymous_variant Exon 11 of 11 1 NM_030930.4 ENSP00000227471.3 Q9H1C4
UNC93B1ENST00000525368.1 linkn.*203C>G downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.00592
AC:
900
AN:
152074
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00210
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00863
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00132
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.00917
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.00609
AC:
582
AN:
95542
AF XY:
0.00603
show subpopulations
Gnomad AFR exome
AF:
0.00134
Gnomad AMR exome
AF:
0.00587
Gnomad ASJ exome
AF:
0.00431
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00196
Gnomad NFE exome
AF:
0.0100
Gnomad OTH exome
AF:
0.00995
GnomAD4 exome
AF:
0.00919
AC:
12387
AN:
1347618
Hom.:
68
Cov.:
30
AF XY:
0.00892
AC XY:
5924
AN XY:
664088
show subpopulations
African (AFR)
AF:
0.00127
AC:
35
AN:
27610
American (AMR)
AF:
0.00574
AC:
172
AN:
29972
Ashkenazi Jewish (ASJ)
AF:
0.00392
AC:
92
AN:
23468
East Asian (EAS)
AF:
0.0000303
AC:
1
AN:
33048
South Asian (SAS)
AF:
0.00173
AC:
130
AN:
74938
European-Finnish (FIN)
AF:
0.00214
AC:
71
AN:
33182
Middle Eastern (MID)
AF:
0.00738
AC:
29
AN:
3930
European-Non Finnish (NFE)
AF:
0.0107
AC:
11418
AN:
1065318
Other (OTH)
AF:
0.00782
AC:
439
AN:
56152
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
734
1468
2203
2937
3671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00591
AC:
899
AN:
152182
Hom.:
6
Cov.:
33
AF XY:
0.00565
AC XY:
420
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.00209
AC:
87
AN:
41546
American (AMR)
AF:
0.00862
AC:
132
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4828
European-Finnish (FIN)
AF:
0.00132
AC:
14
AN:
10620
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.00917
AC:
623
AN:
67948
Other (OTH)
AF:
0.0104
AC:
22
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
43
85
128
170
213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00298
Hom.:
4
Bravo
AF:
0.00649

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

UNC93B1: BP4, BP7, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Herpes simplex encephalitis, susceptibility to, 1 Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.11
DANN
Benign
0.53
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs568350079; hg19: chr11-67759086; API